KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Accounts Payables (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Accounts Payables for 13 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 6.27% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 6.27% year-over-year, with the annual reading at $1.3 million for FY2025, 6.27% down from the prior year.
  • Accounts Payables hit $1.3 million in Q4 2025 for ClearPoint Neuro, up from $723000.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.6 million in Q2 2022 to a low of $272000.0 in Q4 2022.
  • Historically, Accounts Payables has averaged $994650.0 across 5 years, with a median of $960000.0 in 2022.
  • Biggest five-year swings in Accounts Payables: tumbled 49.36% in 2021 and later skyrocketed 240.97% in 2024.
  • Year by year, Accounts Payables stood at $427000.0 in 2021, then plummeted by 36.3% to $272000.0 in 2022, then soared by 44.49% to $393000.0 in 2023, then surged by 240.97% to $1.3 million in 2024, then decreased by 6.27% to $1.3 million in 2025.
  • Business Quant data shows Accounts Payables for CLPT at $1.3 million in Q4 2025, $723000.0 in Q3 2025, and $1.5 million in Q2 2025.